The Dual RAF/MEK Inhibitor CH5126766/RO5126766 May Be a Potential Therapy for RAS-Mutated Tumor Cells

Open Access

Peer-reviewed

Research Article

Makoto Wada,

Affiliations Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
⨯
Mano Horinaka,

Affiliation Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
⨯
Toshikazu Yamazaki,

Affiliation Kamakura Research Laboratory, Research Division, Chugai Pharmaceutical Co., Kamakura, Japan
⨯
Norito Katoh,

Affiliation Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
⨯
Toshiyuki Sakai

* E-mail: tsakai@koto.kpu-m.ac.jp

Affiliation Department of Molecular-Targeting Cancer Prevention, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
⨯

Reader Comments (0)

Melanoma
Is the Subject Area "Melanoma" applicable to this article?

Thanks for your feedback.
Melanoma cells
Is the Subject Area "Melanoma cells" applicable to this article?

Thanks for your feedback.
SW480 cells
Is the Subject Area "SW480 cells" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Skin tumors
Is the Subject Area "Skin tumors" applicable to this article?

Thanks for your feedback.